Sarepta Therapeutics
Neil Johnson is an accomplished finance professional with extensive experience in financial planning and analysis across various pharmaceutical and healthcare organizations. Currently serving as Sr. Director of Financial Planning & Analysis at Sarepta Therapeutics since January 2021, Neil previously held senior finance positions at Q² Solutions, Amneal Pharmaceuticals, and Alexion Pharmaceuticals, among others. Key responsibilities have included managing multi-functional teams, leading budgeting processes, and driving strategic planning initiatives for organizations with significant operational scale. Neil holds an MBA in Finance, Production & Operations Management from The University of Chicago Booth School of Business and a Bachelor of Science in Finance from the University of Illinois Urbana-Champaign.
This person is not in any teams
This person is not in any offices
Sarepta Therapeutics
10 followers
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.